eMedicine Specialties > Pediatrics: General Medicine > Dermatology
Gianotti-Crosti Syndrome: Treatment & Medication
Updated: Sep 29, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Treatment
Medical Care
- Gianotti-Crosti syndrome (GCS) is a benign self-limited condition that requires no treatment.
- Topical steroids are generally not effective, although anecdotal responses have been reported.
- Systemic treatment with antihistamines has been moderately helpful in relieving pruritus.
Consultations
- Consultation with a dermatologist or a pediatric dermatologist should be sought in confusing cases.
- Consultation with a pediatric gastroenterologist should be sought for the rare cases associated with the hepatitis B virus.
Activity
- Activity is limited only by symptoms.
- The infectious period ends when the exanthem appears; therefore, the patient may participate in daycare or school at this time.
Medication
No medical therapy is necessary. Topical corticosteroids and oral antihistamines might provide some symptomatic relief of pruritus.
Corticosteroids, topical cream
These agents may provide relief when pruritus is present.
Triamcinolone 0.1% cream (Aristocort)
Antipruritic effect of this cream is fairly marginal but may be somewhat effective. Treats inflammatory dermatosis that is responsive to steroids. Decreases inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability.
Adult
Apply a thin film to affected areas bid prn
Pediatric
Apply as in adults
None reported
Documented hypersensitivity; fungal, viral, and bacterial skin infections
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Excessive use of topical steroids may cause skin atrophy; do not use in decreased skin circulation; potential for systemic absorption and adrenal suppression when used over large surface areas in young children
Antihistamines
These agents may provide some relief when pruritus is present. They are used to treat minor allergic reactions and anaphylaxis and may be used to pretreat patients with prior documentation of minor allergic reactions. These agents may control itching by blocking effects of endogenously released histamine.
Hydroxyzine (Atarax, Vistaril)
Offers a mild degree of relief from pruritus. Antagonizes H1 receptors in periphery. May suppress histamine activity in the subcortical region of CNS.
Adult
25-50 mg PO q6h prn
Pediatric
1 mg/kg/dose PO q6h prn
May potentiate the effect of opioid analgesics, barbiturates, alcohol, or other CNS depressants
Documented hypersensitivity; early pregnancy
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Associated with clinical exacerbations of porphyria (may not be safe for patients with porphyria); ECG abnormalities (alterations in T waves) may occur; causes drowsiness
More on Gianotti-Crosti Syndrome |
| Overview: Gianotti-Crosti Syndrome |
| Differential Diagnoses & Workup: Gianotti-Crosti Syndrome |
Treatment & Medication: Gianotti-Crosti Syndrome |
| Follow-up: Gianotti-Crosti Syndrome |
| Multimedia: Gianotti-Crosti Syndrome |
| References |
| « Previous Page | Next Page » |
References
Baleviciene G, Maciuleviciene R, Schwartz RA. Papular acrodermatitis of childhood: the Gianotti-Crosti syndrome. Cutis. Apr 2001;67(4):291-4. [Medline].
Caputo R, Gelmetti C, Ermacora E, et al. Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol. Feb 1992;26(2 Pt 1):207-10. [Medline].
Yoshida M, Tsuda N, Morihata T, et al. Five patients with localized facial eruptions associated with Gianotti-Crosti syndrome caused by primary Epstein-Barr virus infection. J Pediatr. Dec 2004;145(6):843-4. [Medline].
Mendoza N, Diamantis M, Arora A, et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol. 2008;9(5):295-305. [Medline].
Draelos ZK, Hansen RC, James WD. Gianotti-Crosti syndrome associated with infections other than hepatitis B. JAMA. Nov 7 1986;256(17):2386-8. [Medline].
Brandt O, Abeck D, Gianotti R, Burgdorf W. Gianotti-Crosti syndrome. J Am Acad Dermatol. 2006;54:136-145. [Medline].
Chuh A, Lee A, Zawar V. The diagnostic criteria of Gianotti-Crosti syndrome: are they applicable to children in India?. Pediatr Dermatol. Sep-Oct 2004;21(5):542-7. [Medline].
Chuh AA. Diagnostic criteria for Gianotti-Crosti syndrome: a prospective case-control study for validity assessment. Cutis. Sep 2001;68(3):207-13. [Medline].
Magyarlaki M, Drobnitsch I, Schneider I. Papular acrodermatitis of childhood (Gianotti-Crosti disease). Pediatr Dermatol. Sep 1991;8(3):224-7. [Medline].
Taieb A, Plantin P, Du Pasquier P, et al. Gianotti-Crosti syndrome: a study of 26 cases. Br J Dermatol. Jul 1986;115(1):49-59. [Medline].
Further Reading
Keywords
Gianotti-Crosti syndrome, GCS, papular acrodermatitis of childhood, papulovesicular acrolocated syndrome, hepatitis B infection, hepatitis B, lymphadenopathy, rash Epstein-Barr virus, papular acrodermatitis, hepatosplenomegaly, inguinal adenopathy, rotavirus, cytomegalovirus, adenovirus, enterovirus, respiratory syncytial virus, parainfluenza virus, Parvovirus, paravaccinia, human herpesvirus 6, echovirus, molluscum contagiosum, human immunodeficiency virus, HIV, group A beta-hemolytic streptococci, Mycobacterium avium-intracellulare, Mycoplasma pneumoniae, Bartonella henselae, Borrelia burgdorferi, meningococcemia, polio, diphtheria, influenza, pertussis, measles, smallpox, hepatitis A
Treatment & Medication: Gianotti-Crosti Syndrome